#ASH2026
LightNews LightNews
eurofinsviracor.bsky.social
The results are in. The next question is always: What do the results mean for my patient? 🧪 That's where specialized diagnostics matter.

Visit Booth 125 at #ASH2026 to discover how advanced testing can deliver important clinical insights.
🔎 www.eurofins-viracor.com/our-testing/

#CAR_T #BMT #ASH26
November 13, 2026 at 7:06 PM
hemehub.bsky.social
🩸 Join HemeHub this December for our Post ASH 2026 live webinar series!

Explore the latest updates in Leukemia, Lymphoma, Classical Hematology, and Myeloma through expert-led sessions.

🔗 Register: hemehub.org/live-webinars

#HemeHub #ASH2026 #ASH26 #Hematology #HematologyOncology #HemeOnc #Myeloma
hemehub.bsky.social hemehub.bsky.social @hemehub.bsky.social · 19d
🩸 Schedule Update for HemeHub’s Post-ASH 2026 Live Webinar Series!

Our Myeloma session will now take place on December 23, while the Leukemia, Lymphoma, and Classical Hematology sessions remain scheduled for December 21.

🔗 Register: hemehub.org/live-webinars

#HemeHub #ASH2026 #PostASH2026
November 10, 2026 at 4:08 AM
hemehub.bsky.social
🩸 Mark your calendars for HemeHub’s Post-ASH 2026 live webinar series this December!

Join us for expert-led updates in Leukemia, Lymphoma, Classical Hematology, and Myeloma.

🔗 Register: hemehub.org/live-webinars

#HemeHub #ASH2026 #ASH26 #Hematology #HematologyOncology #HemeOnc #Myeloma #Leukemia
November 9, 2026 at 5:30 PM
yoshitakahoshi.bsky.social
【anito-celの18カ月データと、Yescartaの5年追跡を発表】
Gilead/Kiteが、ASH 2026で23演題を発表する。anito-celは追跡18カ月でのiMMagine-1データを出し、Yescartaは5年追跡のZUMA-12結果を公表する。Gilead/Kite、ASH2026で23演題発表──anito-celは追跡18カ月でのiMMagine-1データ、Yescartaは5年追跡のZUMA-12結果を公表
stellanews.life/technology/1...
Gilead/Kite、ASH2026で23演題発表──anito-celは追跡18カ月でのiMMagine-1データ、Yescartaは5年追跡のZUMA-12結果を公表
Gilead Sciences傘下Kiteは、米国血液学会（ASH）年次総会にて23演題を発表すると公表した。再発・難治性多発性骨髄腫向けanito-celの18カ月追跡データや、Yescartaの5年追跡ZUMA-12データなどが含まれる。
stellanews.life
November 7, 2026 at 9:54 AM
jyves94.bsky.social
⚡️ #Caribou : Présentations à #ASH2026

#Rémissions complètes pluriannuelles avec #Vispa_Cel, un #CAR_T #Allogénique, pour le #Lymphome ( #ANTLER)

Réponses profondes & durables avec #CB_011, un CAR-T Allogénique, pour le #MyélomeMultiple R/R ( #CaMMouflage)
investor.cariboubio.com/news-release...
November 4, 2026 at 4:05 PM
newsramp.com
Heidelberg Pharma will present Phase 1/2a data on pamlectabart tismanitin (HDP-101) for relapsed/refractory multiple myeloma at #ASH2026, alongside early results for CD37-targeting HDP-102 in B-cell malignancies. Key milestones for its ATAC platform. #Oncology
Image from article
November 5, 2026 at 12:09 AM
hemehub.bsky.social
🩸 Schedule Update for HemeHub’s Post-ASH 2026 Live Webinar Series!

Our Myeloma session will now take place on December 23, while the Leukemia, Lymphoma, and Classical Hematology sessions remain scheduled for December 21.

🔗 Register: hemehub.org/live-webinars

#HemeHub #ASH2026 #PostASH2026
October 26, 2026 at 10:30 PM
hemehub.bsky.social
🌟 Looking forward to our Post-ASH 2026 Updates live webinar series on December 21!

Join HemeHub for expert perspectives on the latest research and advances in hematology.

🌐 Register today: hemehub.org/live-webinars

#HemeHub #ASH2026 #ASH26 #MedEd #Myeloma #Leukemia #Lymphoma #ClassicalHematology
October 21, 2026 at 7:48 PM
hemehub.bsky.social
🩸 Join HemeHub on December 21 for our Post-ASH 2026 live webinar series!

Hear leading experts discuss key #ASH2026 updates in:
• Myeloma
• Leukemia
• Lymphoma
• Classical Hematology

🔗 Register: hemehub.org/live-webinars

#HemeHub #ASH2026 #PostASH2026 #Hematology
October 18, 2026 at 4:24 AM
livemusicarchiveupdates.heads.social.ap.brid.gy
...And You Will Know Us By the Trail of Dead Live at USA on 2026-04-20 https://archive.org/details/ASH2026-04-20
...And You Will Know Us By the Trail of Dead Live at USA on 2026-04-20 : Free Download, Borrow, and Streaming : Internet Archive
Video-Trending-Amateur-Fanhub
archive.org
April 20, 2026 at 4:34 PM
sicklecelluk.bsky.social
Our CEO, John James, is in Virginia attending the American Society of Haematology conference, where he has presented as a guest speaker and joined colleagues in the ASH 5K walk/run. A great opportunity for global learning and collaboration.

#ASH2026 #SickleCellSociety
December 9, 2025 at 1:38 PM
ashandra.bsky.social
Starting my 2026 thread for stuff I finish #Ash2026
February 17, 2026 at 7:31 PM
ashandra.bsky.social
This is the end result 🫶 Thanks to everyone who recommended something! I'll start when january comes 🙂‍↕️ #Ash2026
Kieta Hatsukoi Akane-banashi / After God Rainbow Kaoru Hana wa Rin to Saku (The Fragrant Flower Blooms with Dignity) Vinland Saga / Amayo no Tsuki (The Moon on a Rainy Night) Boys Run the Riot / Sayonara Eri Mikazuki Mao wa Seibetsu wo Erabenai The Beginning After The End / Tomodachi Game Hakushaku to Yousei (Earl and Fairy) / Yawahada ni Shunrai (The Serenade of Spring Thunder) Blue Period Kimi ni Koisuru Satsujinki (Killer in Love) Barajou no Kiss (Kiss of the Rose Princess)
December 23, 2025 at 6:42 PM
onclive.bsky.social
Marc S. Hoffmann, MD, discusses data for sonrotoclax plus zanubrutinib and unmet needs in the mantle cell lymphoma treatment paradigm. @kumedcenter.bsky.social @ash.hematology.org #ASH2026 #lymsm #hematology

www.onclive.com/view/sonroto...
Sonrotoclax Plus Zanubrutinib Paves the Way for the Future of MCL Regimens | OncLive
Marc S. Hoffmann, MD, discusses data for sonrotoclax plus zanubrutinib and unmet needs in the mantle cell lymphoma treatment paradigm.
www.onclive.com
August 6, 2026 at 2:49 PM
leegrimeslab.bsky.social
If you are invited to review abstracts for ASH2026 in a basic science category, please know that I reviewed these sections and pushed for you to do this work. PLEASE HELP ME OUT. We want to increase the quality and representation of basic science at ASH.
May 9, 2025 at 3:18 PM